Fingerprint
Dive into the research topics of 'Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
the SELECT Study Group
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations